IntroductionStandard treatment for neovascular age-related macular degeneration (nAMD) is intravitreal injections of anti-VEGF drugs. Following multiple injections, nAMD lesions often become quiescent but there is a high risk of reactivation, and regular review by hospital ophthalmologists is the norm. The present trial examines the feasibility of community optometrists making lesion reactivation decisions.MethodsThe Effectiveness of Community vs Hospital Eye Service (ECHoES) trial is a virtual trial; lesion reactivation decisions were made about vignettes that comprised clinical data, colour fundus photographs, and optical coherence tomograms displayed on a web-based platform. Participants were either hospital ophthalmologists or community...
Journal Article;Purpose. Spanish retina specialists were surveyed in order to propose actions to dec...
PURPOSE To determine the characteristics and outcomes of eyes with neovascular age-related macular d...
PURPOSE: Management of neovascular age-related macular degeneration (nAMD) has evolved over the last...
Background: Patients with neovascular age-related macular degeneration (nAMD) usually attend regular...
Background Patients with neovascular age-related macular degeneration (nAMD) usually attend regular ...
BackgroundPatients with neovascular age-related macular degeneration (nAMD) usually attend regular r...
Objectives To assess the cost-effectiveness of optometrist-led follow-up monitoring reviews for pati...
Objectives: To compare the ability of ophthalmologists versus optometrists to correctly classify ret...
ObjectivesTo assess the cost-effectiveness of optometrist-led follow-up monitoring reviews for patie...
Objective Management of age-related macular degeneration (AMD) places a high demand on already const...
implementation of a study to investigate the effectiveness of community vs hospital eye service foll...
OBJECTIVE: Management of age-related macular degeneration (AMD) places a high demand on already cons...
Purpose. Spanish retina specialists were surveyed in order to propose actions to decrease deficienci...
Purpose. Spanish retina specialists were surveyed in order to propose actions to decrease deficienci...
Background/aims To evaluate the cost-effectiveness of non-invasive monitoring tests to detect the on...
Journal Article;Purpose. Spanish retina specialists were surveyed in order to propose actions to dec...
PURPOSE To determine the characteristics and outcomes of eyes with neovascular age-related macular d...
PURPOSE: Management of neovascular age-related macular degeneration (nAMD) has evolved over the last...
Background: Patients with neovascular age-related macular degeneration (nAMD) usually attend regular...
Background Patients with neovascular age-related macular degeneration (nAMD) usually attend regular ...
BackgroundPatients with neovascular age-related macular degeneration (nAMD) usually attend regular r...
Objectives To assess the cost-effectiveness of optometrist-led follow-up monitoring reviews for pati...
Objectives: To compare the ability of ophthalmologists versus optometrists to correctly classify ret...
ObjectivesTo assess the cost-effectiveness of optometrist-led follow-up monitoring reviews for patie...
Objective Management of age-related macular degeneration (AMD) places a high demand on already const...
implementation of a study to investigate the effectiveness of community vs hospital eye service foll...
OBJECTIVE: Management of age-related macular degeneration (AMD) places a high demand on already cons...
Purpose. Spanish retina specialists were surveyed in order to propose actions to decrease deficienci...
Purpose. Spanish retina specialists were surveyed in order to propose actions to decrease deficienci...
Background/aims To evaluate the cost-effectiveness of non-invasive monitoring tests to detect the on...
Journal Article;Purpose. Spanish retina specialists were surveyed in order to propose actions to dec...
PURPOSE To determine the characteristics and outcomes of eyes with neovascular age-related macular d...
PURPOSE: Management of neovascular age-related macular degeneration (nAMD) has evolved over the last...